Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide +/- Fludarabine in Refractory CLL/SLL
NCT00009984Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by National Cancer Institute. Started Mar 2002; status: terminated.
02
Drugs
thalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00009984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009984.